Cardiovascular effects of selective COX-2 inhibition: is there a class effect? The International COX-2 Study Group.

Abstract

The International COX-2 Study Group, a panel of independent physicians and scientists, convened January 28-30, 2005, in Washington, DC, to discuss the issues concerning the cardiovascular (CV) profile of coxibs. The purpose of the meeting was to review potential mechanisms by which inhibition of COX-2 by selective and nonselective NSAID could increase risk… (More)

Topics

Cite this paper

@article{Crofford2006CardiovascularEO, title={Cardiovascular effects of selective COX-2 inhibition: is there a class effect? The International COX-2 Study Group.}, author={Leslie J. Crofford and Matthew D. Breyer and C Vibeke Strand and Frank Rushitzka and Kay Brune and Michael E. Farkouh and Lee S. Simon}, journal={The Journal of rheumatology}, year={2006}, volume={33 7}, pages={1403-8} }